Edition:
United States

People: Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

76.15EUR
29 Jul 2016
Change (% chg)

€-0.14 (-0.18%)
Prev Close
€76.29
Open
€76.86
Day's High
€76.86
Day's Low
€74.00
Volume
3,087,074
Avg. Vol
2,685,771
52-wk High
€101.10
52-wk Low
€62.50

Witz, Pascale 

Ms. Pascale Witz is Executive Vice President in charge of Global Divisions & Strategic Commercial Development, and a Member of the Executive Committee and the Global Leadership Team of Sanofi SA, effective as of July 1, 2013. She has been President & Chief Executive Officer of Medical Diagnostics at GE Healthcare since 2009. She started her career in a research lab before moving to marketing at Becton Dickinson France in 1991. She joined GE Healthcare in 1996 as Product Manager for the vascular business in France. Over the years, she also worked within GE in Europe, Africa, Middle East and the United States. Prior to taking up the position of President & CEO of the medical diagnostics business, she was VP & General Manager for the Global Interventional Business for France and United States (2008-2009). Throughout her career within GEHC, Ms. Witz headed up a number of businesses. She was General Manager, Computed Tomography (2006-2007), VP Sales & Marketing Services (2005-2006), General Manager, Nuclear Medicine & PET (2002-2004), VP Information Technology and VP Six Sigma and Quality (2000-2001). She holds a Master's degree in life sciences/molecular biology from Institut National des Sciences Appliquees Lyon and an MBA from INSEAD.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --